PolyPid
PolyPid offers a technology platform that enables a controlled and prolonged release of any active pharmaceutical ingredients (API).
Total raised
€43M
€43,000,000
Funding rounds
1
Investors
0
distinct backers
Active since
2019-06
latest 2019-06
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood21
base rate 53% for Series D+
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-07-01 | Series D+ | €43M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Trax€791MIsrael · Software
- Oura Health€779MFinland · Healthtech